X-Biotix Therapeutics

Biotechnology, Health Care, Therapeutics
Founded in 2016-01-01
Waltham, Massachusetts, United States
http://www.x-biotixrx.com/
For Profit

About X-Biotix Therapeutics

X-Biotix Therapeutics specializes in the development of novel small molecule antibiotic scaffolds for multi-drug resistant (MDR) gram-negative pathogens to address the urgent and growing global threat of antibiotic resistance. It applies a multi-target strategy to generate a pipeline of effective antibiotics with inhibitory activity against a wide range of biological targets in essential pathways of gram-negative bacterial cells and which are also predicted to defeat known antibiotic resistance mechanisms. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 7000000 USD
  • Last Funding: 7000000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

X-Biotix Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Therapeutics

Headquarters: Waltham, Massachusetts, United States